DE:XIN Stock Latest News
Company AnnouncementsShandong Xinhua Pharma Posts Lower Nine‑Month Profit Despite Asset Growth5d ago
Company AnnouncementsXinhua Pharmaceutical’s Nimodipine Tablets Clear China’s Generic Consistency Review2w ago
Company AnnouncementsShandong Xinhua Pharma Calls EGM to Approve New Executive Director2w ago
Company AnnouncementsShandong Xinhua Pharmaceutical Sets Board Meeting to Review Nine-Month Results2w ago
Company AnnouncementsShandong Xinhua Pharma Proposes Board Appointment of Senior Economist Liu Weimin3w ago
Company AnnouncementsXinhua Pharmaceutical Wins Approval for Sacubitril Valsartan Tablets in China3w agoCompany AnnouncementsShandong Xinhua Subsidiary Wins Approval for Donepezil Orally Disintegrating Tablets in China1M ago
Company AnnouncementsShandong Xinhua Pharma Wins Approval for Levocarnitine Oral Solution1M ago- Company AnnouncementsShandong Xinhua Subsidiary Wins Key Generic Consistency Approval for Azithromycin2M ago
- Company AnnouncementsShandong Xinhua Wins NMPA Approval for Dapoxetine Tablets2M ago
Company AnnouncementsShandong Xinhua Pharmaceutical Releases Unaudited 2026 Interim Results2M ago
Company AnnouncementsXinhua Pharmaceutical Wins China Approval for Dapagliflozin Tablets2M agoCompany AnnouncementsShandong Xinhua Pharmaceutical Schedules Board Meeting to Review 2026 Interim Results2M ago
Company AnnouncementsShandong Xinhua Pharmaceutical Declares 2025 Final Dividend and Clarifies Tax Arrangements4M ago
Company AnnouncementsShandong Xinhua Pharmaceutical Shareholders Approve All AGM Resolutions and 2025 Dividend Plan4M ago- Company AnnouncementsXinhua Pharmaceutical Wins Approval to Begin Clinical Trials for Novel Pain Drug LXH-21034M ago
Company AnnouncementsShandong Xinhua Pharmaceutical Wins China Approval for Sevelamer Carbonate Suspension5M ago- Company AnnouncementsShandong Xinhua Pharmaceutical Sets AGM to Review 2025 Results and Governance Changes5M ago
Company AnnouncementsXinhua Pharmaceutical’s Phenobarbital Tablets Clear China’s Generic Consistency Evaluation5M agoCompany AnnouncementsShandong Xinhua Pharmaceutical Wins NMPA Approval for New Ambroxol–Clenbuterol Oral Solution5M ago
Company AnnouncementsShandong Xinhua Pharmaceutical Wins NMPA Approval for Benserazide Hydrochloride API5M ago